Singapore, May 7 -- IDT Australia has been awarded a Victoria State Government grant to part fund the establishment of Australia's first cGMP Antibody-Drug-Conjugate (ADC) manufacturing facility.

The grant from the Victorian Industry Investment Fund (VIIF) stream of the Victorian Jobs and Investment Fund (VJIF) is for IDT Australia's new $3.8 million commercial Contract Design and Manufacturing Organisation (CDMO) facility in Boronia, Victoria for ADCs - a new class of oncology drugs that precisely target cancer cells while sparing healthy ones.

IDT has established early relationships with ADC biotech companies including a master services agreement with Nagase & Co., a globally renowned Japanese pharmaceutical supplier, to develop and m...